DGX vs GEMI · P/E 22, rev $5.94B vs rev $179.6M
Quest Diagnostics Incorporated (DGX) versus Gemini Space Station, Inc. Class A Common Stock (GEMI) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Gemini Space Station, Inc. Class A Common Stock (GEMI) is a capital markets company listed on NASDAQ.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported GEMI revenue for 2025-12-31 was $179.6M. Net income was -$582.8M. Revenue was up 26.3% from 2024-12-31 to 2025-12-31. GEMI currently screens at market cap $630.9M.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. GEMI currently screens at market cap $630.9M.
Not investment advice. Open the DGX and GEMI stock pages for the full models.
Not investment advice.